Accendra Health Ord Shs: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Unternehmen

Accendra Health Ord Shs Informationen



Börsenkürzel- -

Name des Unternehmens- -

IPO-datum- -

CEO- -

Anzahl der mitarbeiter- -

Wertpapierart- -

Geschäftsjahresende- -

Addresse- -

Stadt- -

Börse- -

Land- -

Postleitzahl- -

Telefon- -

Website- -

Börsenkürzel- -

IPO-datum- -

CEO- -

Führungskräfte von Accendra Health Ord Shs



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Edward A. Pesicka

President, Chief Executive Officer, Director

1.15M

-3.06%

Mr. Perry A. Bernocchi

Chief Operating Officer, Executive Vice President

342.66K

+31.72%

Mr. Jonathan A. Leon

Chief Financial Officer, Executive Vice President, Principal Accounting Officer

303.59K

+28.02%

Mr. Robert J. (Bob) Henkel

Independent Director

66.26K

+43.64%

Mr. Kenneth (Kenny) Gardner-Smith

Independent Director

54.92K

+52.65%

Lt. Gen. Gwendolyn M. Bingham

Independent Director

22.18K

--

Mr. Mark A. Beck

Independent Chairman of the Board

--

Mr. Stephen W. (Steve) Klemash

Independent Director

--

Ms. Rita F. Johnson-Mills

Independent Director

--

Ms. Teresa L. Kline

Independent Director

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Edward A. Pesicka

President, Chief Executive Officer, Director

1.15M

-3.06%

Mr. Perry A. Bernocchi

Chief Operating Officer, Executive Vice President

342.66K

+31.72%

Mr. Jonathan A. Leon

Chief Financial Officer, Executive Vice President, Principal Accounting Officer

303.59K

+28.02%

Mr. Robert J. (Bob) Henkel

Independent Director

66.26K

+43.64%

Mr. Kenneth (Kenny) Gardner-Smith

Independent Director

54.92K

+52.65%

Lt. Gen. Gwendolyn M. Bingham

Independent Director

22.18K

--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Diabetes

201.37M

28.88%

Sleep therapy

185.80M

26.65%

Home respiratory therapy

107.26M

15.38%

Other

72.59M

10.41%

Ostomy

53.27M

7.64%

Andere

76.98M

11.04%

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Diabetes

201.37M

28.88%

Sleep therapy

185.80M

26.65%

Home respiratory therapy

107.26M

15.38%

Other

72.59M

10.41%

Ostomy

53.27M

7.64%

Andere

76.98M

11.04%

Aktionärsstatistik

Aktualisiert: Thu, Feb 19

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Coliseum Capital Management, L.L.C.

17.14%

The Vanguard Group, Inc.

7.89%

BlackRock Institutional Trust Company, N.A.

6.44%

Charles Schwab Investment Management, Inc.

5.31%

D. E. Shaw & Co., L.P.

4.66%

Andere

58.57%

Aktionäre

Anteil

Coliseum Capital Management, L.L.C.

17.14%

The Vanguard Group, Inc.

7.89%

BlackRock Institutional Trust Company, N.A.

6.44%

Charles Schwab Investment Management, Inc.

5.31%

D. E. Shaw & Co., L.P.

4.66%

Andere

58.57%

Aktionärstypen

Aktionäre

Anteil

Hedge Fund

38.32%

Investment Advisor

27.22%

Investment Advisor/Hedge Fund

21.30%

Research Firm

5.74%

Individual Investor

3.78%

Pension Fund

0.67%

Venture Capital

0.36%

Bank and Trust

0.34%

Insurance Company

0.03%

Andere

2.24%

Institutionelle Beteiligung



Aktualisiert: Sat, Jan 3

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2026Q1

506

75.40M

97.49%

-21.05M

2025Q4

536

75.76M

97.95%

-18.97M

2025Q3

546

76.01M

98.30%

-20.79M

2025Q2

540

78.13M

101.97%

-17.96M

2025Q1

543

77.64M

100.50%

-19.65M

2024Q4

538

79.04M

102.40%

-14.25M

2024Q3

552

79.41M

103.01%

-12.06M

2023Q4

582

79.41M

103.81%

-13.04M

2023Q2

583

76.62M

100.55%

-10.57M

2023Q1

597

75.96M

99.69%

-10.66M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Coliseum Capital Management, L.L.C.

13.10M

16.96%

+1.54M

+13.30%

Sep 30, 2025

The Vanguard Group, Inc.

5.75M

7.43%

-2.15M

-27.27%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

4.88M

6.32%

-5.09M

-51.04%

Sep 30, 2025

Charles Schwab Investment Management, Inc.

3.21M

4.15%

+133.51K

+4.34%

Sep 30, 2025

D. E. Shaw & Co., L.P.

2.32M

3%

+890.92K

+62.34%

Sep 30, 2025

Invenomic Capital Management LP

2.75M

3.55%

+2.75M

--

Sep 30, 2025

Dimensional Fund Advisors, L.P.

3.51M

4.53%

-750.61K

-17.63%

Sep 30, 2025

Millennium Management LLC

3.26M

4.22%

+2.14M

+191.71%

Sep 30, 2025

Geode Capital Management, L.L.C.

1.46M

1.89%

-313.56K

-17.67%

Sep 30, 2025

Two Sigma Investments, LP

1.51M

1.96%

+422.35K

+38.75%

Sep 30, 2025

Verbundene ETFs



Aktualisiert: Sat, Jan 3

Name

Anteil

State Street SPDR S&P Health Care Services ETF

0.36%

Royce Quant Small-Cap Quality Value ETF

0.27%

DoubleLine Fortune 500 Equal Weight ETF

0.22%

Vanguard US Value Factor ETF

0.12%

Indexperts Quality Earnings Focused ETF

0.11%

Schwab Fundamental U.S. Small Company ETF

0.07%

First Trust Active Factor Small Cap ETF

0.04%

WisdomTree US SmallCap Fund

0.03%

Invesco Russell 2000 Dynamic Multifactor ETF

0.03%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.02%

State Street SPDR S&P Health Care Services ETF

Anteil0.36%

Royce Quant Small-Cap Quality Value ETF

Anteil0.27%

DoubleLine Fortune 500 Equal Weight ETF

Anteil0.22%

Vanguard US Value Factor ETF

Anteil0.12%

Indexperts Quality Earnings Focused ETF

Anteil0.11%

Schwab Fundamental U.S. Small Company ETF

Anteil0.07%

First Trust Active Factor Small Cap ETF

Anteil0.04%

WisdomTree US SmallCap Fund

Anteil0.03%

Invesco Russell 2000 Dynamic Multifactor ETF

Anteil0.03%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Anteil0.02%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten